Literature DB >> 30225208

Preface: lung cancer in never smokers.

Adi F Gazdar1.   

Abstract

Entities:  

Year:  2018        PMID： 30225208      PMCID： PMC6131179          DOI： 10.21037/tlcr.2018.06.06

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN： 2218-6751


× No keyword cloud information.
  6 in total

Review 1.  From Mice to Men and Back: An Assessment of Preclinical Model Systems for the Study of Lung Cancers.

Authors:  Adi F Gazdar; Fred R Hirsch; John D Minna
Journal:  J Thorac Oncol       Date:  2015-12-24       Impact factor: 15.609

Review 2.  Lung cancer in never smokers: a review.

Authors:  Janakiraman Subramanian; Ramaswamy Govindan
Journal:  J Clin Oncol       Date:  2007-02-10       Impact factor: 44.544

3.  Lung cancer incidence in never smokers.

Authors:  Heather A Wakelee; Ellen T Chang; Scarlett L Gomez; Theresa H Keegan; Diane Feskanich; Christina A Clarke; Lars Holmberg; Lee C Yong; Laurence N Kolonel; Michael K Gould; Dee W West
Journal:  J Clin Oncol       Date:  2007-02-10       Impact factor: 44.544

Review 4.  Lung cancer in never smokers--a different disease.

Authors:  Sophie Sun; Joan H Schiller; Adi F Gazdar
Journal:  Nat Rev Cancer       Date:  2007-10       Impact factor: 60.716

5.  Mutational signatures associated with tobacco smoking in human cancer.

Authors:  Ludmil B Alexandrov; Young Seok Ju; Kerstin Haase; Peter Van Loo; Iñigo Martincorena; Serena Nik-Zainal; Yasushi Totoki; Akihiro Fujimoto; Hidewaki Nakagawa; Tatsuhiro Shibata; Peter J Campbell; Paolo Vineis; David H Phillips; Michael R Stratton
Journal:  Science       Date:  2016-11-04       Impact factor: 47.728

6.  Lung adenocarcinoma of never smokers and smokers harbor differential regions of genetic alteration and exhibit different levels of genomic instability.

Authors:  Kelsie L Thu; Emily A Vucic; Raj Chari; Wei Zhang; William W Lockwood; John C English; Rong Fu; Pei Wang; Ziding Feng; Calum E MacAulay; Adi F Gazdar; Stephen Lam; Wan L Lam
Journal:  PLoS One       Date:  2012-03-07       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.